Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-08T20:46:11.488Z Has data issue: false hasContentIssue false

Toward equitable payment for inclusive participation

Published online by Cambridge University Press:  27 February 2023

Justin X. Moore
Affiliation:
Cancer Prevention, Control, & Population Health Program, Georgia Cancer Center, Department of Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA
LaKesha N. Anderson
Affiliation:
Department of Medicine, Uniformed Services University, Bethesda, MD, USA
Cynthia Li
Affiliation:
Medical College of Georgia, Augusta University, Augusta, GA, USA
Reginald D. Benson Jr.
Affiliation:
Medical College of Georgia, Augusta University, Augusta, GA, USA
Alejandra Garcia Rychtarikova
Affiliation:
Department of Family and Community Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA
Lillie D. Williamson
Affiliation:
Department of Communication Arts, University of Wisconsin-Madison, Madison, WI, USA
Leslie E. Wolf
Affiliation:
Center for Law, Health & Society, Georgia State University College of Law, Atlanta, GA, USA
Ebony B. Whisenant
Affiliation:
Department of Family and Community Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA
Erin Roark
Affiliation:
Katherine Reese Pamplin College of Arts, Humanities, and Social Sciences at Augusta University, Augusta, GA, USA
Samantha R. Jones
Affiliation:
Department of Family and Community Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA
Christy J.W. Ledford*
Affiliation:
Department of Family and Community Medicine, Medical College of Georgia at Augusta University, Augusta, GA, USA
*
Address for correspondence: C.J.W. Ledford, PhD, Department of Family and Community Medicine, Medical College of Georgia at Augusta University, 1120 15th Street, Augusta, GA, 30912, USA. Email: chledford@augusta.edu
Rights & Permissions [Opens in a new window]

Abstract

Type
Perspective
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of The Association for Clinical and Translational Science

Oppressed peoples are always being asked to stretch a little more, to bridge the gap between blindness and humanity.

– Audre Lorde

Because of discrimination and exclusion, historically marginalized populations continue to experience disparities in health, wealth, education, housing, and employment and have been described as “vulnerable” in the research context [Reference UyBico, Pavel and Gross1]. Researchers and institutional review boards (IRBs) persistently assert that payments may be “unduly influential” and undermine the voluntariness of consent [Reference Gelinas, Largent, Cohen, Kornetsky, Bierer and Fernandez Lynch2Reference Halpern, Chowdhury and Bayes4]. However, this potentially unwarranted ethical concern may result in imbalanced payments. Participant payment structures that calculate reimbursement based on participant work income assign relative value to participation, providing participants with lower income lower financial payment [Reference Stones and McMillan5]. Underrepresentation in research may be exacerbated by payment structures that deter participation, such as requiring participants to share social security numbers or other identifying information [Reference Bierer, White, Gelinas and Strauss6].

Although translational science demonstrates that payments themselves are successful in increasing recruitment [Reference Anderson and McNair7], there is little consensus on how to ethically and inclusively structure payments. Payment structure is more than simply the amount of payment. Bioethicists conceptualize participant payments in four ways: appreciation, reimbursement, compensation, and incentive [Reference Gelinas, Largent, Cohen, Kornetsky, Bierer and Fernandez Lynch2,Reference Resnik8]. A 2005 analysis of 467 IRB-approved protocols offering payments to research participants found protocols rarely provide the rationale for payment [Reference Grady, Dickert, Jawetz, Gensler and Emanuel3].

To better understand current payment practices, our team conducted a content analysis of four journals (Annals of Family Medicine, Annals of Internal Medicine, American Journal of Emergency Medicine, and American Journal of Obstetrics and Gynecology), which publish clinical and translational research to inform clinical practice. Among 519 articles reviewed, 203 studies included human participants whose participation ranged from surveys or interviews to multiple blood draws and medical procedures. Only 5.4% (11 of 203) described a payment for research participation; and of these, only 9 provided information regarding payment types and structure (Table 1). Among papers that disclosed payment information, payment detail varied, see Table 2. Payments were more frequently given to healthcare workers than community or clinical participants, which may indicate a transactional approach. This finding directly diverges from the recommendation that payments “should reflect the general value of the time and burdens associated with the study” rather than factors like participant earning potential [Reference Gelinas, Largent, Cohen, Kornetsky, Bierer and Fernandez Lynch2].

Table 1. Characteristics of published studies that enrolled human participants

* The sampling frame included the first six issues of 2017–2019 for three journals (AFM, AIM, AJOG) and the first three issues 2017–2019 for AJEM.

** Vulnerable populations included: “women (in the context of diagnosing coronary heart disease),” “women who underwent fetoscopic laser therapy for twin-twin transfusion syndrome,” “suicide attempters,” “socioeconomically deprived areas,” “patients with depression,” “older adults,” “Community Health Centers,” “Black pregnant women,” and “pregnant smokers.” Notably, some papers described populations that our research team would have qualified as vulnerable, but the published papers did not use these terms or similar concepts, such as male youths who had been found guilty of serious criminal offense or women seeking abortion.

Table 2. Full description of participant payments

Two conclusions can be drawn from these findings: 1) studies are not publishing payment information or 2) studies are underutilizing payments in recruitment. Clinical and translational science research studies should adopt more rigorous reporting guidelines regarding payment of research participants so we can determine which of these conclusions is correct.

Failure to publish payment information prevents us from understanding the use of payment in research and whether it is effective and equitable. Standardized clinical research guidelines increase reproducibility and enable fellow researchers to better understand methodological approaches. A standardized approach to describing payments may provide utility in contextualizing a study’s findings. Current guidelines such as the Consolidated Standards of Reporting Trials (CONSORT) do not include reporting of participant payments. We specifically recommend that researchers describe four features of payment structure: amount, rationale, mechanism, and timing. Our recommendation extends the 2019 Secretary’s Advisory Committee on Human Research Protections recommendation [9] from justification in IRB protocols to presenting the rationale in dissemination activities. Standardized dissemination could facilitate much needed research on investigator practices of paying research participants. Such information could lead to more ethical, equitable treatment of research participants and trust in the research enterprise.

To better understand the inclusion of populations, studies should also describe limitations of the study’s payment structure. None of the studies here described how the process of payment, such as collecting social security numbers, excludes vulnerable populations. This practice limits inclusion of populations who do not have access to federal identification systems, such as homeless individuals or undocumented workers. Vulnerable populations already have higher levels of mistrust in medical research [Reference Smirnoff, Wilets and Ragin10]. Requiring collection of personal information limits inclusion of populations whose distrust of systems, informed by historic research abuses such as the US Public Health Service Tuskegee Syphilis Study [Reference Katz, Kegeles and Kressin11], regulates how they disclose personal information.

Underutilization of payments in recruitment may slow research progress, but if, as our sample suggests, patient and community participants are least likely to receive payment, these practices may undermine efforts for more inclusive research. Mistrust is not only an antecedent of research participation but also a potential outcome. How participants feel about payment structures, including underpayment, may reinforce some of the ideas and beliefs that underlie mistrust (e.g., mistreatment, being used, etc.).

Given the historical context and untrustworthy behavior by US public health systems to vulnerable groups, we must be cognizant of how researchers are perceived by populations of interest for recruitment [Reference Smirnoff, Wilets and Ragin10]. Critical approaches to health scholarship have called for researchers to interrogate the ways in which we engage with persistently marginalized communities, encouraging consideration of the needs and criteria that are important to communities [Reference Dutta12]. Researchers should not unilaterally assign value to participation, particularly since perceptions of the amount of fair payment varies by race and ethnicity [Reference Liu, Elliott, Strelnick, Aguilar-Gaxiola and Cottler13]. Community consultation and partnership not only will help determine fair payment that facilitates participation by providing reimbursement, adequate compensation, and incentives [Reference Gelinas, Largent, Cohen, Kornetsky, Bierer and Fernandez Lynch2] but also what creates equitable, reciprocal relationships with communities [Reference Black, Hardy and De Marco14]. The inclusion of community members is particularly important for communities who have experienced mistreatment and may continue to have fraught relationships with medical research [Reference Smirnoff, Wilets and Ragin10].

The appropriateness of compensation and judgments of inconvenience or disruption can differ depending on the cultural values and perspectives of participants [Reference Saleh, Sambakunsi, Nyirenda, Kumwenda, Mortimer and Chinouya15]. For instance, the same monetary value given in cash versus gift cards has implications for use. Festinger and Dugosh found that individuals given cash were more likely to pay for transportation and bills, whereas participants given gift cards were more likely to purchase household items [Reference Festinger and Dugosh16]. Community input and inclusion in creating the payment structure may ensure that participants receive payments in a meaningful and useful way. It may also reduce the imperious stereotype of researchers.

Due to the dearth of information about payment processes, it is unclear the extent to which researchers are engaging in these activities or how they have done so effectively. Future research should further elaborate on participant payments and consider participants as co-researchers [Reference Shen, Doyle-Thomas and Beesley17] in human subjects research as a mechanism toward greater equity in research.

Acknowledgments

The authors thank Dean Seehusen for his contribution to the sampling plan and rationale and Lauren Cafferty for her contributions to the coding scheme and process.

Disclosures

The authors declare no conflict of interest.

References

UyBico, SJ, Pavel, S, Gross, CP. Recruiting vulnerable populations into research: a systematic review of recruitment interventions. Journal of General Internal Medicine 2007; 22(6): 852863. DOI: 10.1007/s11606-007-0126-3.CrossRefGoogle ScholarPubMed
Gelinas, L, Largent, EA, Cohen, IG, Kornetsky, S, Bierer, BE, Fernandez Lynch, H. A framework for ethical payment to research participants. New England Journal of Medicine 2018; 22(8): 766771. DOI: 10.1056/NEJMsb1710591.CrossRefGoogle Scholar
Grady, C, Dickert, N, Jawetz, T, Gensler, G, Emanuel, E. An analysis of U.S. practices of paying research participants. Contemporary Clinical Trials 2005; 26(3): 365375. DOI: 10.1016/j.cct.2005.02.003.CrossRefGoogle ScholarPubMed
Halpern, SD, Chowdhury, M, Bayes, B, et al. Effectiveness and ethics of incentives for research participation: 2 randomized clinical trials. JAMA Internal Medicine 2021; 1(11): 14791488. DOI: 10.1001/jamainternmed.2021.5450.CrossRefGoogle Scholar
Stones, M, McMillan, J. Payment for participation in research: a pursuit for the poor? Journal of Medical Ethics. 2010; 36(1): 3436. DOI: 10.1136/jme.2009.030965.CrossRefGoogle ScholarPubMed
Bierer, BE, White, SA, Gelinas, L, Strauss, DH. Fair payment and just benefits to enhance diversity in clinical research. Journal of Clinical and Translational Science 2021; 5(1): e159. DOI: 10.1017/cts.2021.816.CrossRefGoogle ScholarPubMed
Anderson, E, McNair, L. Ethical issues in research involving participants with opioid use disorder. Therapeutic Innovation and Regulatory Science 2018; 52(3): 280284. DOI: 10.1177/2168479018771682.CrossRefGoogle ScholarPubMed
Resnik, DB. Bioethical issues in providing financial incentives to research participants. Medicolegal and Bioethics 2015; 5: 3541. DOI: 10.2147/mb.S70416.CrossRefGoogle ScholarPubMed
Addressing Ethical Concerns Offers of Payment to Research Participants. Office for Human Research Protections, US Department of Health and Human Services. (https://www.hhs.gov/ohrp/sachrp-committee/recommendations/attachment-a-september-30-2019/index.html)Google Scholar
Smirnoff, M, Wilets, I, Ragin, DF, et al. A paradigm for understanding trust and mistrust in medical research: the Community VOICES study. AJOB Empirical Bioethics 2018; 9(1): 3947. DOI: 10.1080/23294515.2018.1432718.CrossRefGoogle ScholarPubMed
Katz, RV, Kegeles, SS, Kressin, NR, et al. The Tuskegee Legacy Project: willingness of minorities to participate in biomedical research. Journal of Health Care for the Poor and Underserved. 2006; 17(4): 698715. DOI: 10.1353/hpu.2006.0126.CrossRefGoogle ScholarPubMed
Dutta, MJ. The critical cultural turn in health communication: reflexivity, solidarity, and praxis. Health Communication 2010; 25(6-7): 534539. DOI: 10.1080/10410236.2010.497995.CrossRefGoogle ScholarPubMed
Liu, Y, Elliott, A, Strelnick, H, Aguilar-Gaxiola, S, Cottler, LB. Asian Americans are less willing than other racial groups to participate in health research. Journal of Clinical and Translational Science. 2019; 3(2-3): 9096. DOI: 10.1017/cts.2019.372.CrossRefGoogle ScholarPubMed
Black, KZ, Hardy, CY, De Marco, M, et al. Beyond incentives for involvement to compensation for consultants: increasing equity in CBPR approaches. Progress in Community Health Partnerships 2013; 7(3): 263270. DOI: 10.1353/cpr.2013.0040.CrossRefGoogle ScholarPubMed
Saleh, S, Sambakunsi, H, Nyirenda, D, Kumwenda, M, Mortimer, K, Chinouya, M. Participant compensation in global health research: a case study. International Health. 2020; 12(6): 524532.CrossRefGoogle ScholarPubMed
Festinger, DS, Dugosh, KL. Paying substance abusers in research studies: where does the money go? American Journal of Drug and Alcohol Abuse 2012; 38(1): 4348. DOI: 10.3109/00952990.2011.563337.CrossRefGoogle ScholarPubMed
Shen, S, Doyle-Thomas, KAR, Beesley, L, et al. How and why should we engage parents as co-researchers in health research? A scoping review of current practices. Health Expectations 2017; 20(4): 543554. DOI: 10.1111/hex.12490.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Characteristics of published studies that enrolled human participants

Figure 1

Table 2. Full description of participant payments